Stock-Based Compensation for Eli Lilly (LLY)
Stock-Based Compensation for Eli Lilly (LLY): headline value $626.00M · YoY -3.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
LLY
Currently viewingStock-Based CompensationSwitch metric
Latest period
$626.00M
YoY change
-3.0%
5Y CAGR
+15.2%
Peak year (2024)
$645.60M
Latest annual
$626.00M
Stock-Based Compensation history chart for Eli Lilly (LLY) from 1989 to 2025
Stock-Based Compensation history table for Eli Lilly (LLY) from 1989 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $626.00M | -3.0% | ||
| 2024 | $645.60M | +2.7% | ||
| 2023 | $628.50M | +69.4% | ||
| 2022 | $371.10M | +8.3% | ||
| 2021 | $342.80M | +11.3% | ||
| 2020 | $308.10M | -1.4% | ||
| 2019 | $312.40M | +11.8% | ||
| 2018 | $279.50M | -0.6% | ||
| 2017 | $281.30M | +10.2% | ||
| 2016 | $255.30M | +17.2% | ||
| 2015 | $217.80M | +39.6% | ||
| 2014 | $156.00M | +7.7% | ||
| 2013 | $144.90M | +2.4% | ||
| 2012 | $141.50M | -4.0% | ||
| 2011 | $147.40M | -36.2% | ||
| 2010 | $231.00M | -37.3% | ||
| 2009 | $368.50M | +44.3% | ||
| 2008 | $255.30M | — | ||
| 2007 | $0 | — | ||
| 2006 | $0 | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — | ||
| 1990 | $0 | — | ||
| 1989 | $0 | — |
Stock-Based Compensation values are taken from Eli Lilly's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Eli Lilly (LLY) reported stock-based compensation of $626.00M – edged down 3.0% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Eli Lilly stock-based compensation compounded at +15.2% per year, with the latest reading among the more recent periods of the dataset.
The dataset's maximum stock-based compensation sits at $645.60M (2024); the minimum reading of $0 dates to 1989.
Among 8 Healthcare peers, Eli Lilly (LLY) ranks 4th; the peer median for stock-based compensation is $0.
Eli Lilly Stock-Based Compensation by Year
Eli Lilly Stock-Based Compensation 2025: $626.00M
Eli Lilly stock-based compensation in 2025 was $626.00M, edged down 3.0% below 2024.
Eli Lilly Stock-Based Compensation 2024: $645.60M
Eli Lilly stock-based compensation in 2024 was $645.60M, edged up 2.7% from 2023. This figure represents the highest annual value in the available history.
Eli Lilly Stock-Based Compensation 2023: $628.50M
Eli Lilly stock-based compensation in 2023 was $628.50M, surged 69.4% from 2022.
Eli Lilly Stock-Based Compensation 2022: $371.10M
Eli Lilly stock-based compensation in 2022 was $371.10M, grew 8.3% from 2021.
Eli Lilly Stock-Based Compensation 2021: $342.80M
Eli Lilly stock-based compensation in 2021 was $342.80M.
See more financial history for Eli Lilly (LLY).
Sector peers — Stock-Based Compensation
Companies in the same sector as Eli Lilly, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $0 | Healthcare |
Frequently asked questions
What is Eli Lilly's stock-based compensation?
Latest reported stock-based compensation for Eli Lilly (LLY) is $626.00M (period ending December 31, 2025).
How has Eli Lilly stock-based compensation changed year-over-year?
Eli Lilly (LLY) stock-based compensation changed -3.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Eli Lilly stock-based compensation?
Eli Lilly (LLY) stock-based compensation compound annual growth rate is +15.2% over the most recent 5 years available.
When did Eli Lilly stock-based compensation hit its highest annual value?
Eli Lilly stock-based compensation reached its highest annual value of $645.60M in 2024.
What was Eli Lilly stock-based compensation in 2024?
Eli Lilly (LLY) stock-based compensation in 2024 was $645.60M.
What was Eli Lilly stock-based compensation in 2025?
Eli Lilly (LLY) stock-based compensation in 2025 was $626.00M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
LLY Overview
Company profile, financial tools, and key metrics
LLY Revenue Counter
Earns $2,067 every second. See per minute, hour, and day.
LLY Earnings Counter
Earns $654.44 per second net profit. See per minute, hour, and day.
LLY Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
LLY What If Invested
What if you had invested $1,000? See historical returns from any date.
LLY How It Makes Money
Discover visual breakdown of $65.18B in revenue — where it comes from and where it goes.
LLY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
LLY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
LLY Daily Price Character
Steady · 48.0% historical win rate (green days). Streaks & record days.
LLY Buybacks
0.43% TTM buyback yield. Shareholder yield & SBC comparison.
LLY Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
LLY Dividend Profile
Yield: 0.73%. Safety: 8/8. See full history.
LLY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
LLY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.